Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00780559 · ClinicalTrials.gov registry record · NA
Improving Neuropathy and Mobility in People With Early Diabetes
A NA study of Diabetes and Physical Activity, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 3
- Study locations
NCT00780559: Completed NA study of Diabetes and Physical Activity, sponsored by VA Office of Research and Development.
NCT00780559 is a NA study of Diabetes and Physical Activity that has completed, run by VA Office of Research and Development. The registered enrollment target is 72 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00780559, a NA study of Diabetes and Physical Activity, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine if an individually tailored diet and physical enhancement program can improve mobility, physical activity, and neuropathy in people with early diabetes.
Primary Outcome
Measures distance covered by participant when walking at a brisk pace without running for six minutes in feet.
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Tailored Diet and Physical Activity
Study Locations (3)
Maryland
- University of Maryland - Baltimore
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore
Michigan
- VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2009-11-01 |
| Est. Completion | 2018-02-08 |
| Phase | NA |
What the finished NCT00780559 record still lists
NCT00780559 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT00780559 reports a single indexed study location in Maryland, Michigan.
Frequently Asked Questions
What is clinical trial NCT00780559 about?
NCT00780559 is a clinical study titled "Improving Neuropathy and Mobility in People With Early Diabetes". The purpose of this study is to determine if an individually tailored diet and physical enhancement program can improve mobility, physical activity, and neuropathy in people with early diabetes.
What is the current status of trial NCT00780559?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2009-11-01. Estimated completion is 2018-02-08.
What conditions does trial NCT00780559 study?
This clinical trial studies the following conditions: Diabetes, Physical Activity.
What interventions are being tested in trial NCT00780559?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Tailored Diet and Physical Activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT00780559?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00780559 being conducted?
This trial has 3 study locations across Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00780559's enrollment target sits among peer trials
72 221st of 338 higher than 117 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI